Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Pancreas Cancer
Interventions: DRUG: mFOLFIRINOX|DRUG: Doxorubicin|DRUG: Cyclophosphamid|DRUG: Paclitaxel|DRUG: Carboplatin
Sponsor: Moscow Clinical Scientific Center